Effect of Food on the Bioavailability of SDZ DJN 608, an Oral Hypoglycemic Agent, from a Tablet and a Liquid-Filled Capsule in the Dog
- 1 January 1996
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 13 (3) , 440-444
- https://doi.org/10.1023/a:1016004928627
Abstract
Purpose. The effect of food on the bioavailability of SDZ DJN 608, a D-phenylalanine derivative, was investigated in three mature, male beagle dogs. Methods. Each dog received, under fasting and postprandial conditions, a 30 mg oral dose as a tablet (T) and a liquid-filled capsule (LC). Additionally, a 5 mg intravenous dose was given in the fasting state. Doses in the same dog were separated by 1-week washout periods. Serial plasma samples were collected for 24 h postdose and analyzed for SDZ DJN 608 using HPLC. Model-independent pharmacokinetic parameters were compared between treatments by 3-way ANOVA. In vitro dissolution profiles of T and LC were generated using the USP paddle method. In addition, the transport of SDZ DJN 608 through a Caco-2 cell monolayer was examined at concentrations of 0.1 and 1 mM, in the absence and presence of an aromatic amino acid, L-α-methyldopa, the transport of which is mediated by the large neutral amino acid (LNAA) carrier. Results. In the dog, SDZ DJN 608 was rapidly absorbed. The peak plasma concentration (Cmax) averaged higher, and the peak time (tmax) shorter, after LC than T, though the differences were not statistically significant. This finding is consistent with in vitro dissolution data showing that, at both pH 1.2 and pH 6.8, the dissolution rate of LC was faster than that of T. No significant difference in the area under curve (AUC) was observed between LC and T, the absolute bioavailability of both being complete in the fasting state. Whereas the presence of food showed little effect on the tmax and Cmax of either dosage form, it significantly reduced the AUC, the effect (ca −20%) being not different between LC and T. In the Caco-2 model, the mucosal-to-serosal permeability of SDZ DJN 608 was independent of concentration and unaffected by L-α-methyldopa, suggesting passive diffusion of the former. Conclusions. Food had little effect on the absorption rate but significantly reduced the bioavailability of SDZ DJN 608 regardless of the dosage form. This effect is unlikely to be caused by inhibition of the transepithelial transport of SDZ DJN 608 by amino acids in the diet.Keywords
This publication has 12 references indexed in Scilit:
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Possibility of ideal blood glucose control by a new oral hypoglycemic agent, N-[(trans-4-isopropylcyclohexyl)-carbonyl]-d-phenylalanine (A-4166), and its stimulatory effect on insulin secretion in animalsDiabetes Research and Clinical Practice, 1991
- Transport of a large neutral amino acid (phenylalanine) in a human intestinal epithelial cell line: Caco-2Biochimica et Biophysica Acta (BBA) - Biomembranes, 1990
- Caco-2 Cell Monolayers as a Model for Drug Transport Across the Intestinal MucosaPharmaceutical Research, 1990
- Mechanism of L-α-Methyldopa Transport Through a Monolayer of Polarized Human Intestinal Epithelial Cells (Caco-2)Pharmaceutical Research, 1990
- N-(Cyclohexylcarbonyl)-D-phenylalanines and related compounds. A new class of oral hypoglycemic agents. 2Journal of Medicinal Chemistry, 1989
- Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeabilityGastroenterology, 1989
- INTESTINAL-ABSORPTION OF ALPHA-METHYLDOPA - INVITRO MECHANISTIC STUDIES IN RAT SMALL INTESTINAL SEGMENTS1987
- The influence of food on the absorption of antimicrobial agentsJournal of Antimicrobial Chemotherapy, 1982
- Influence of Food on the Bioavailability of DrugsClinical Pharmacokinetics, 1978